PD‐1/PD‐L1 expression in pediatric duodenal biopsies: Association with mucosal activity and diagnostic performance in celiac disease

OBJECTIVES: The role of immune checkpoint molecules (ICMs) in celiac disease (CD) remains incompletely understood despite their expected function in limiting mucosal immune-mediated injury. This study aimed to evaluate duodenal PD-1 and PD-L1 expression in pediatric duodenal samples, investigate associations with histologic/serologic activity, and assess their diagnostic performance. METHODS: Patients' files who applied to the pediatric gastroenterology clinic and underwent esophagogastroduodenoscopy between 01.01.2022 and 31.12.2023 were retrospectively reviewed. CD was defined by European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)-based clinicopathologic correlation. PD-1/PD-L1 immunohistochemistry was quantified as the number of positive mononuclear cells per HPF (40x) in the lamina propria in hot spot areas. The diagnostic potential in differentiating CD and non-CD cases was investigated with receiver operating characteristics (ROC) analysis. RESULTS: A total of 142 children (mean age 10.3 ± 4.4 years; 64.8% male); 68 (47.9%) had CD, and 74 (52.1%) served as non-CD controls. Both markers were significantly elevated in CD tissues (p < 0.001). In ROC analysis, PD-L1 outperformed PD-1 for identifying CD (area under the curve: 0.933 vs. 0.809). A PD-L1 > 6.5/HPF cut-off yielded 92.6% sensitivity and 83.8% specificity. PD-L1 was associated with an increase in Marsh grade in CD samples (p = 0.033) and with an increase in IEL in non-CD cases (p = 0.016). CONCLUSION: PD-1 and PD-L1 are specifically increased in CD, and PD-L1 could be a candidate diagnostic marker for CD. In autoimmune disorders such as CD, elucidating the interactions, functional capacities, and degrees of involvement of these molecules can provide insights into the pathogenesis, diagnosis, and treatment.

Authors

Institutions

Publication Details

Journal
Journal of Pediatric Gastroenterology and Nutrition
Published
2026-11-12
DOI
https://doi.org/10.1002/jpn3.70629
Primary Topic
Celiac Disease Research and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

PD‐1/PD‐L1 expression in pediatric duodenal biopsies: Association with mucosal activity and diagnostic performance in celiac disease

Gül Şeker, Fatih Yılmaz
Journal of Pediatric Gastroenterology and Nutrition
Celiac Disease Research and Management
article

PD‐1/PD‐L1 expression in pediatric duodenal biopsies: Association with mucosal activity and diagnostic performance in celiac disease

Gül Şeker, Fatih Yılmaz
article en

Abstract

OBJECTIVES: The role of immune checkpoint molecules (ICMs) in celiac disease (CD) remains incompletely understood despite their expected function in limiting mucosal immune-mediated injury. This study aimed to evaluate duodenal PD-1 and PD-L1 expression in pediatric duodenal samples, investigate associations with histologic/serologic activity, and assess their diagnostic performance. METHODS: Patients' files who applied to the pediatric gastroenterology clinic and underwent esophagogastroduodenoscopy between 01.01.2022 and 31.12.2023 were retrospectively reviewed. CD was defined by European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)-based clinicopathologic correlation. PD-1/PD-L1 immunohistochemistry was quantified as the number of positive mononuclear cells per HPF (40x) in the lamina propria in hot spot areas. The diagnostic potential in differentiating CD and non-CD cases was investigated with receiver operating characteristics (ROC) analysis. RESULTS: A total of 142 children (mean age 10.3 ± 4.4 years; 64.8% male); 68 (47.9%) had CD, and 74 (52.1%) served as non-CD controls. Both markers were significantly elevated in CD tissues (p < 0.001). In ROC analysis, PD-L1 outperformed PD-1 for identifying CD (area under the curve: 0.933 vs. 0.809). A PD-L1 > 6.5/HPF cut-off yielded 92.6% sensitivity and 83.8% specificity. PD-L1 was associated with an increase in Marsh grade in CD samples (p = 0.033) and with an increase in IEL in non-CD cases (p = 0.016). CONCLUSION: PD-1 and PD-L1 are specifically increased in CD, and PD-L1 could be a candidate diagnostic marker for CD. In autoimmune disorders such as CD, elucidating the interactions, functional capacities, and degrees of involvement of these molecules can provide insights into the pathogenesis, diagnosis, and treatment.

Journal of Pediatric Gastroenterology and Nutrition
Mardin Artuklu University (TR), Izmir Tepecik Eğitim ve Araştırma Hastanesi (TR)
Celiac Disease Research and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon